The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong Kong
ACNC
1 other identifier
observational
5,000
1 country
1
Brief Summary
The primary objective of this study is to analyze the 15-year cumulative incidence of advanced colorectal neoplasia and CRC-related mortality after the index colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 9, 2024
February 1, 2024
3.9 years
March 23, 2021
February 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Culumative incidence of advanced colorectal neoplasia
high-risk adenomas or CRC after 15 years of index conoloscopy
15 years
Secondary Outcomes (1)
CRC-related mortality rate
15 years
Study Arms (4)
Normal finding
Colonoscopy finding normal
Hyperplastic polyps
Colonoscopy finding of hyperplastic polyps
Low-risk adenomas
Colonoscopy finding of low-risk adenomas
High-risk adenomas
Colonoscopy finding of high-risk adenomas
Eligibility Criteria
We will identify patients from CDARS with colonoscopy performed from 1 January 2000 to 31 October 2020. Other relevant diagnoses, procedures, concomitant drugs, laboratory parameters and pathology results will be retrieved and studied.
You may qualify if:
- \. All patients with colonoscopy performed in HA hospitals during the study period would be eligible for screening.
You may not qualify if:
- \. Patients with documented personal history of colorectal cancers before the study period would be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Specialist
Study Record Dates
First Submitted
March 23, 2021
First Posted
March 25, 2021
Study Start
January 1, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share IPD with other researchers